Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer-Reference-Cited by-同舟云学术

Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer

Published:2017-06-05 Issue:2 Volume:165 Page:293-300
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Heimes A.-S.^ORCID,Madjar K.,Edlund K.,Battista M. J.,Almstedt K.,Elger T.,Krajnak S.,Rahnenführer J.,Brenner W.,Hasenburg A.,Hengstler J. G.,Schmidt M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-017-4327-0/fulltext.html

Reference28 articles.

1. Schumacher T, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 348(6230):69–74

2. Denkert C et al (2010) Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(1):105–113

3. Salgado R et al (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 26(2):259–271

4. Iglesia MD et al (2016) Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst 108(11):144

5. Rody A et al (2009) T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res 11(2):R15

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy;Cancers;2023-09-29

2. Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer;Biomedicines;2022-10-21

3. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09

4. Role of chemokine systems in cancer and inflammatory diseases;MedComm;2022-06

5. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT;Cancer Cell International;2021-12